- Home
- Publications
- Publication Search
- Publication Details
Title
Pretubulysin: a new option for the treatment of metastatic cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 1, Pages e1001-e1001
Publisher
Springer Nature
Online
2014-01-16
DOI
10.1038/cddis.2013.510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mcl-1 Ubiquitination and Destruction
- (2015) Hiroyuki Inuzuka et al. Oncotarget
- Indirubin Derivative 6BIO Suppresses Metastasis
- (2013) S. Braig et al. CANCER RESEARCH
- Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives
- (2012) S Rath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Translating TRAIL-receptor targeting agents to the clinic
- (2012) Martha W. den Hollander et al. CANCER LETTERS
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
- (2012) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy
- (2012) Jürgen Eirich et al. Molecular BioSystems
- Strategies for the discovery and development of therapies for metastatic breast cancer
- (2012) Bedrich L. Eckhardt et al. NATURE REVIEWS DRUG DISCOVERY
- Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy
- (2012) Jennifer Herrmann et al. PLoS One
- Role of the ubiquitin ligase Fbw7 in cancer progression
- (2011) Yabin Cheng et al. CANCER AND METASTASIS REVIEWS
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Total Syntheses of Tubulysins
- (2010) Taku Shibue et al. CHEMISTRY-A EUROPEAN JOURNAL
- On the potential of natural products in the discovery of pharma leads: A case for reassessment
- (2010) Samuel Danishefsky NATURAL PRODUCT REPORTS
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Pretubulysin, a Potent and Chemically Accessible Tubulysin Precursor fromAngiococcus disciformis
- (2009) Angelika Ullrich et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents
- (2009) T Sánchez-Pérez et al. CELL DEATH AND DIFFERENTIATION
- Myxobacteria—‘microbial factories’ for the production of bioactive secondary metabolites
- (2009) Silke C. Wenzel et al. Molecular BioSystems
- Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8
- (2009) S Häcker et al. ONCOGENE
- First Total Synthesis of Tubulysin B
- (2009) Orlando Pando et al. ORGANIC LETTERS
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
- (2009) J. W.-H. Li et al. SCIENCE
- Imagable 4T1 model for the study of late stage breast cancer
- (2008) Kai Tao et al. BMC CANCER
- Mcl-1: A Gateway to TRAIL Sensitization
- (2008) S.-H. Kim et al. CANCER RESEARCH
- Natural products in drug discovery
- (2008) A HARVEY DRUG DISCOVERY TODAY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now